Dose Escalated Proton Beam Therapy or Photon Therapy for Esophageal Cancer
Status:
Withdrawn
Trial end date:
2018-12-11
Target enrollment:
Participant gender:
Summary
This study will evaluate if proton beam therapy as part of chemoradiation results in a
decrease in diffusion lung capacity of carbon monoxide (DLCO) compared to photon radiation
therapy for esophageal carcinoma. A secondary objective is to determine effects on cardiac
function, quality of life, and compare acute and late toxicities.